**Core tip:** Bacillus subtilis (*B. subtilis*) is considered a non-pathogenic microorganism of the genus *Bacillus* and a common laboratory contaminant. We present herein, a rare case of spontaneous cerebral abscess caused by *B. subtilis*, evolved in a previously healthy immunocompetent male patient. *B. subtilis* was isolated from both the capsule and pus of the surgically excised brain abscess. Severe tooth decay and periodontitis were the only potential infectious foci. This case highlights the ultimate importance of appropriate oral hygiene and dental care to avoid potentially serious infectious complications and second, *B. subtilis* should not be considered merely as laboratory contaminant especially when cultivated by appropriate central nervous system specimen.

INTRODUCTION
============

The bacterial genus bacillus contains predominantly non-pathogenic microorganisms for humans except for the anthrax bacillus. *Bacillus subtilis* (*B. subtilis*) is a Gram-positive bacterium, rod-shaped and catalase-positive that is ubiquitous in the environment and are normally found in soil and vegetation\[[@B1]\]. This microorganism is considered non-pathogenic for humans. The eye has been the organ most commonly infected by *B. subtilis*, majorly by direct inoculation\[[@B2]\]. Only scarce reports of central nervous system infection by *B. subtilis* have been previously published, all in the form of purulent meningitis\[[@B1],[@B3],[@B4]\]. We present herein, the first case of spontaneous cerebral abscess by *B. subtilis*, evolved in a previously healthy male patient.

CASE PRESENTATION
=================

Chief complaints
----------------

A 51-year-old man presented to the Emergency Department of our hospital complaining of worsening left upper limb weakness. During his presentation in Emergency Department he experienced a generalized tonic-clonic grand mal seizure.

History of present illness
--------------------------

Patient's symptoms started a month ago with recurrent episodes of left upper limb weakness, which had been worsened the last 48 h.

History of past illness
-----------------------

The patient had a free previous medical history.

Physical examination
--------------------

After seizure cessation, the patient's temperature was 36.6 °C, heart rate was 93 bpm, respiratory rate was 16 breaths per minute, blood pressure was 180/90 mmHg and oxygen saturation in room air was 98%. The clinical neurological examination revealed left-sided facial numbness and left upper limb hypoesthesia, a Glasgow Coma scale of 15/15, without any other pathological signs. Our clinical considerations were first a space-occupying brain lesion and second a stroke.

Laboratory examinations
-----------------------

Blood analysis revealed a mild leukocytosis 12 × 10^9^/L, with predominant neutrophils (80%) with normal haematocrit and platelet count. Prothrombin and partial thromboplastin times were normal, and d-dimers were slightly increased at 0.80 μg/mL. Serum C-reactive protein was increased at 4.5 mg/dL (normal range \< 0.8 mg/dL) and erythrocyte sedimentation rate at 30 mm/h. The blood biochemistries, as well as urine analysis were normal. Electrocardiogram, chest X-ray and arterial blood gas were also normal.

Imaging examinations
--------------------

An initial imaging evaluation with brain computed tomography (CT) scan, revealed a 3.2 cm hypodense lesion at right upper parietal lobe. Following contrast media administration, the lesion showed peripheral enhancement. No midline shift was noted.

Brain lesion was further evaluated with a brain magnetic resonance imaging (MRI) scan. The latter revealed a 3.3 cm × 2.7 cm lesion at the right parietal lobe surrounded by mild vasogenic edema, which included the posterior central gyrus. The core of the lesion showed relatively homogenous restricted diffusion (Figure [1](#F1){ref-type="fig"}). Post Gadolinium T1W1 image, revealed a ring-shaped enhancement. Dural enhancement, due to involvement of the adjacent dura was also revealed (Figure [1C](#F1){ref-type="fig"}). Due to the aforementioned imaging findings, differential diagnosis mainly included the presence of a brain abscess, while the possibility of a restricted diffusion metastatic lesion could not entirely be excluded.

![Pre-operative brain magnetic resonance imaging scan with intravenous Gadolinium administration. A: Axial diffusion-weighted imaging (DWI) image shows high signal of the lesion in right upper parietal lobe (black arrow); B: Axial DWI ADC map reveals low signal at the same area, due to restricted diffusion (white arrow); C: Axial post-Gd image, shows rim enhancement of the lesion (white arrowhead) as well as enhancement of the adjacent dura (white arrow).](WJCC-6-1169-g001){#F1}

Further diagnostic work-up
--------------------------

The patient was further evaluated with blood cultures, urine and stool cultures and examination for ova and parasites which turned out negative. Transthoracic cardiac ultrasound was negative for cardiac vegetations or signs of infection. Considering the facts that blood cultures were negative, our patient had not prosthetic heart valves, congenital heart disease, previous endocarditis, heart murmur or stigmata of endocarditis, transthoracic cardiac ultrasound is sufficient to rule out endocarditis, when the patient presents an optimal echocardiographic window, as in the presented case\[[@B5]\]. Dental examination, including panoramic dental X-ray, revealed poor oral hygiene with severe tooth decay and periodontal disease but without detection of dental abscess. Serology tests for human immunodeficiency virus, human T-lymphotropic virus-1 and virus-2, herpes simplex virus, Epstein-Barr virus, cytomegalovirus and toxoplasma, were negative. Wright, rapid plasma reagin tests and tuberculin skin test were also negative. Serum angiotensin-converting enzyme and protein electrophoresis were normal. Serum complement and levels of immunoglobulins were all normal, as follows: C3: 123 mg%, C4: 27 mg%, IgA: 136 mg/dL, IgG: 1200 mg/dL IgM: 120 mg/dL, IgE: 18 IU/mL, IgD: 15 IU/mL. Total lymphocyte count (1.8 × 10^9^/L) and CD4+ percentage (45%), as well as their absolute count (810 cells/μL), were normal. A full panel of serum tumour markers CEA (1.5 ng/mL), CA 19.9 (12.4 U/mL), CA 125 (8 U/mL), PSA (0.208 ng/mL), α-FP (2.2 IU/mL), β-hCG (0.10 mIU/mL) and β-2-microglobulin (1.35 mg/L) were unrevealing. Abdominal and chest CT scans with intravenous contrast media administration did not reveal any infectious focus or neoplastic lesion. Upper and lower gastrointestinal tract endoscopies were also normal.

Microbiological identification of the causative agent
-----------------------------------------------------

The etiological factor of patient's brain abscess, and its susceptibility profile in antibiotics, was determined by using appropriate microbiological analysis. Specifically, pus and capsule tissue of the excised brain lesion were subjected to Gram stain, Acid-Fast Bacilli stain and cultures for aerobes, anaerobes, fungi and mycobacteria. The samples were initially enriched in Thioglycolate broth, incubated overnight and then inoculated onto blood agar plates, McConkey agar plates, Sabouraud agar plates, anaerobe growth media (N-S anaerobe selective supplement, G-N anaerobe selective supplement), and Löwenstein--Jensen medium. Cultures of both pus and capsule tissue grew *B. subtilis*. Identification of the bacillus was performed by Gram stain, catalase production, motility test and BBL™ Crystal™ Identification Systems for Gram Positive bacteria (BD Diagnostics, Le Pont de Claix, France). Gram stain revealed the presence of Gram-positive rods forming subterminal spors, with a positive motility test, catalase, o-nitrophenyl-β-d-galactopyranoside (ONPG), and citrate (Simmons') tests. It was identified as *B. subtilis*, by BBL™ GP Crystal™ Identification Systems (bionumber 2450563773, BD Diagnostics). Antibiotic susceptibility testing was performed by the disk diffusion, and a gradient method (Etest, bioMerieux), according to EUCAST guidelines\[[@B6]\]. Antibiogram demonstrated sensitivity of the microorganism to penicillin, vancomycin, ciprofloxacin, gentamicin and tetracyclines and resistance to clindamycin and rifampicin.

MULTIDISCIPLINARY EXPERT CONSULTATION
=====================================

Georgios Gatzounis, MD, PhD, Professor and Chief, Department of Neurosurgery, University of Patras Medical School
-----------------------------------------------------------------------------------------------------------------

The patient should undergo surgical treatment with right parietal craniotomy and total excision of the brain lesion.

***Stelios F Assimakopoulos, MD, PhD, Assistant Professor of Internal Medicine, Infectious Diseases Specialist, Department of Internal Medicine and Division of Infectious Diseases, University of Patras Medical School; and Markos Marangos, MD, PhD, Professor of Infectious Diseases, Chief of the Division of Infectious Diseases, University of Patras Medical School***

Brain abscess should be treated with appropriate empiric antibiotic coverage including Ceftriaxone 2 g bid, Vancomycin 1 g TID and Metronidazole 500 mg QID. After the results of pus and capsule tissue cultures, which grew *B. subtilis*, and susceptibility testing, Metronidazole and Vancomycin should be discontinued, and the patient continue Ceftriaxone 2 g bid intravenously for 4 wk. Two additional weeks of oral amoxicillin/clavulanic acid 1 g bid is required for treatment completion. Also, the patient should be evaluated for infectious foci and potential underlying immunosuppression, since *B. subtilis* is considered a non-pathogenic microorganism for humans.

Petros Zampakis, MD, PhD, Assistant Professor of Interventional Neuroradiology, Department of Radiology, University of Patras Medical School
--------------------------------------------------------------------------------------------------------------------------------------------

The radiological differential diagnosis mainly includes the presence of a brain abscess, while the possibility of a restricted diffusion metastatic lesion could not entirely be excluded.

Fevronia Kolonitsiou, MD, PhD, Associate Professor of Microbiology, Department of Microbiology, University of Patras Medical School
-----------------------------------------------------------------------------------------------------------------------------------

The microbiological analysis of pus and capsule tissue of the excised brain lesion showed as etiological factor of patient's brain abscess a considered "non-pathogenic" member of the genus *Bacillus*, *B. subtilis*.

FINAL DIAGNOSIS
===============

The final diagnosis of the presented case is spontaneous cerebral abscess due to *B. subtilis*.

TREATMENT
=========

The patient, following his presenting grand mal seizure in the Emergency Department, was immediately started on dexamethasone 8 mg TID intravenously and phenytoin sodium 300 mg QD orally, without seizure relapse. Considering the brain MRI findings, brain lesion was primarily characterized as brain abscess and empiric intravenous antibiotic therapy with Ceftriaxone 2 g bid, Vancomycin 1 g TID and Metronidazole 500 mg QID was administered. The patient underwent surgical treatment with right parietal craniotomy and total excision of the lesion. After the results of pus and capsule tissue cultures, which grew *B. subtilis*, and susceptibility testing, Metronidazole and Vancomycin were discontinued, and the patient continued Ceftriaxone 2 g bid intravenously for 4 wk. Upon completion of four weeks of intravenous antibiotic therapy with ceftriaxone, the patient was discharged from the hospital free of symptoms, on oral amoxicillin/clavulanic acid 1 g bid for two additional weeks.

OUTCOME AND FOLLOW-UP
=====================

The patient had an uneventful postoperative clinical course, whilst dexamethasone was decreased progressively until its cessation. At follow-up visit, two months after surgical removal of cerebral abscess (one month after hospital discharge), the patient was asymptomatic, and a new MRI scan showed complete removal of the abscess with only minor post-operative findings at the adjacent dura (Figure [2](#F2){ref-type="fig"}). The patient was advised to treat his dental decay and periodontitis and take care of his oral health and hygiene.

![Follow-up brain magnetic resonance imaging scan with intravenous Gadolinium administration, at two months post operation. A: diffusion-weighted imaging shows complete removal of the lesion, with normal diffusion of the brain parenchyma; B: Axial post-Gd image, shows minimal enhancement of the adjacent dura, due to the previous surgery (white arrow).](WJCC-6-1169-g002){#F2}

DISCUSSION
==========

Brain abscess is a focal infectious collection within the brain parenchyma, which can arise as a complication of a variety of infections, trauma, or surgery. Bacteria can invade the brain either by direct spread, which accounts for 20% to 60% of cases, or through hematogenous seeding, which typically causes multiple lesions\[[@B7],[@B8]\]. A wide range of pathogens can be involved as causative agents in a brain abscess. The microbial profile depends on both how the brain abscess develops and the integrity of patient's immune system. Mostly a single microbe is isolated, whereas isolation of multiple pathogens has also been described\[[@B9]\]. Aerobic Gram-positive cocci are most commonly encountered and include: viridans streptococci, *Streptococcus milleri*, microaerophilic streptococci, *Streptococcus pneumoniae* (rare) and *Staphylococcus aureus*\[[@B9]\]. Anaerobic bacteria are also common constituents of brain abscesses, originating from odontogenic or otorhinolaryngeal infections\[[@B10]\]. In the immunocompromised host, brain abscess can be caused by opportunistic pathogens, like *Toxoplasma gondii*, *Listeria*, *Nocardia asteroides* and fungi.

The etiologic agent in the presented case was a "non-pathogenic" member of the genus *Bacillus*, *B. subtilis*. Only scarce reports implicate this microorganism in human infections. A number of case reports refer to localized ocular infections, by direct inoculation of this organism in the eye, while a fulminating panophthalmitis following penetrating trauma with the vitreous humour has been also described\[[@B2]\]. Also, epidemics of food poisoning attributed to *B. subtilis* have been previously reported\[[@B11]\]. Regarding implication of *B. subtilis* or other non-anthrax *Bacillus* species in disseminated infections, an old review collectively presented 12 cases; eight presenting as meningitis, three bacteraemias and one peritonitis/pericarditis\[[@B1]\]. In meningitis cases, direct portal of entry to the meninges was reported in four patients, while 5 out of 8 patients with meningitis had a fatal outcome. *B. subtilis* was identified as etiological factor in six of 12 cases; three cases of bacteraemia and three cases of meningitis. We were able to find two additional reports of purulent meningitis by *B. subtilis*, one complicating a penetrating head injury\[[@B3],[@B4]\]. Collectively, five cases of central nervous system (CNS) infection by *B. subtilis* have been previously reported, all in the form of purulent meningitis, while direct inoculation of the organism in the CNS seems to be an important pathogenetic factor.

To the best of our knowledge, the presented case is the first in the literature describing the evolution of a cerebral abscess by *B. subtilis*. The rarity of the presented case is also highlighted by the facts that no direct portal of infection existed, as in most previously described cases of *B. subtilis* meningitis, nor underlying immunosuppression. Our patient was a healthy man with no previous serious or recurrent or unusual infections, HIV testing was negative, total lymphocyte count and CD4+ percentage, as well as their absolute count, were normal and he was not suffering from underlying malignancy, chronic kidney disease or diabetes mellitus. Regarding the potential mechanism of evolution of cerebral abscess in our patient, the only possible explanation could be the hematogenous spread from the only infectious foci detected, which was the severe tooth decay and periodontitis. *Bacillus* organisms are often found in the mouth, although they do not appear to be part of the permanent oral flora\[[@B12]\]. Previous studies of odontogenic infections, demonstrated dental caries as the most prevalent predisposing factor, whilst in HIV negative patients, anaerobic bacilli were detected as etiologic agents in 12%\[[@B13]\].

Our patient was successsfully treated with combined total surgical excision of brain abscess, followed by 4 wk of intravenous antibiotic therapy and two weeks of oral therapy, according to antimicrobial susceptibility results. A comprehensive consensus document on controversial issues for the treatment of infections of the central nervous system, published by the Italian Study Group on Severe Infections, recommends that abscesses \> 2.5 cm should be surgically removed, followed by 4-6 wk of appropriate antibiotic therapy\[[@B14]\]. Four weeks of intravenous therapy with an antibiotic which exerts favourable pharmacokinetic profile in brain tissue is reasonable. Ceftriaxone at a dose of 2 g bid, which was administered in our patient, is a preferable option if the microorganism has proven susceptible. The total duration of treatment could be completed by sequential oral antibiotics for 2-4 wk, given that susceptible pathogens have been isolated and orally given antibiotics could achieve adequate penetration in brain tissue. In this context, Amoxicillin/clavulanic, which was given to the present patient, trimethoprim-sulfamethoxazole, fluoroquinolone, linezolid and rifampicin are considered effective oral antibiotic options in such cases.

In conclusion, organisms of the genus *Bacillus*, except for *B. anthracis*, are not usually considered pathogenic for humans. Occasionally these bacteria can cause serious infections, even in immunocompetent patients, especially if introduced into the vitreous of the eye or subarachnoid space by trauma or iatrogenically. This case highlights the ultimate importance of appropriate oral hygiene and dental care to avoid potentially serious infectious complications and second, *B. subtilis* should not be considered merely as laboratory contaminant especially when cultivated by appropriate CNS specimen.

CONCLUSION
==========

Only scarce reports of *B. subtilis* central nervous system infection have been reported, mainly in the form of pyogenic meningitis, usually in cases of direct inoculation by trauma or iatrogenically. *B. subtilis* is a very rare cause of spontaneous cerebral abscess. *B. subtilis* should not be considered merely as laboratory contaminant, especially when cultivated by appropriate CNS specimen. Appropriate oral hygiene and dental care is of ultimate importance of to avoid potentially serious infectious complications.
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